Researchers get closer to universal flu jab

Scientists are a step closer to a universal flu vaccine
Researchers have made further advancements that could put an end to the need for annual flu jabs through the development of a universal flu vaccine.
Although a universal flu vaccine is a still a long way off, a team from Sanofi found this latest jab could be up to ten times as effective as current vaccines.
Tests have been carried out on animal models to verify the results, with the scientists now hopeful they will be able to conduct clinical trials to prove the efficacy of the drug.
The team used spikes that stick out from the influenza virus and fused them with a transporter protein that is naturally found in blood.
Administering the vaccine in ferrets, they found the animals were resistant to batches of flu viruses that were common between 1934 and 2007.
In an interview with the BBC, chief scientific officer at Sanofi Dr Gary Nabel said: "We think this is a step down the path towards a universal vaccine. It's not a universal vaccine yet."
Related News
-
News Strategies for managing an outsourcing partner
Robust oversight linked to increased efficiency and better communication with outsourcing partners. -
News Updated: CPHI North America 2022 Blog
Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. -
News Greater standardisation needed for effective ESG reporting - Expert panel
Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. -
News MedPharm: Increased investment driving developments in topical drugs market
We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. -
News Pharmapack Awards 2022: Winners Revealed
The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. -
News What it means to be 'At the heart of Pharma'
Informa Markets colleagues explain the motivations behind CPHI’s rebrand. -
News CPhI Podcast Series: Leveraging data science for sustainable autoinjector development
Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction. -
News Thermo Fisher and Charles River join consortium using robotics to produce cell therapies at scale
The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes.
Position your company at the heart of the global Pharma industry with a CPhI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPhI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance